{
    "2021-04-02": [
        [
            {
                "time": "",
                "orginal_text": "药明康德（603259.SH）：认缴120Capital的1588.0899万美元份额",
                "features": {
                    "keywords": [
                        "药明康德",
                        "认缴",
                        "120Capital",
                        "医疗健康",
                        "私募基金"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "四大CXO企业2020年成绩单大比拼：药明康德营收净利拔头筹，国内“狼多肉少”头部企业海外寻订单",
                "features": {
                    "keywords": [
                        "药明康德",
                        "营收",
                        "净利",
                        "CXO",
                        "海外订单"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医药行业周报：一季报行情开启 建议关注高增长的医药板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "一季报",
                        "高增长",
                        "医药板块"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "药明康德（603259.SH）拟认购一专注于医疗健康等领域私募基金份额",
                "features": {
                    "keywords": [
                        "药明康德",
                        "认购",
                        "私募基金",
                        "医疗健康"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "药明康德现1笔大宗交易 共成交2,203.20万元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "药明康德今日大宗交易成交15万股，成交价146.88元溢价0.0%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "大宗交易",
                        "成交价",
                        "溢价"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "全球CRO市值第一的药明康德交出了好业绩，但估值虚高阴影未散",
                "features": {
                    "keywords": [
                        "药明康德",
                        "CRO",
                        "市值",
                        "业绩",
                        "估值虚高"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "药明康德（603259）：新增订单情况良好 长期看好业绩增长",
                "features": {
                    "keywords": [
                        "药明康德",
                        "新增订单",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "中航证券 - 药明康德：成长高确定性，长期看好【公司研究】",
                "features": {
                    "keywords": [
                        "药明康德",
                        "成长",
                        "高确定性",
                        "长期看好"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "中航证券维持药明康德买入评级，2020年报点评：成长高确定性，长期看好",
                "features": {
                    "keywords": [
                        "药明康德",
                        "买入评级",
                        "2020年报",
                        "成长",
                        "高确定性"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "光大证券 - 药明康德：2020年业绩符合预期，未来持续强劲增长可期【公司研究】",
                "features": {
                    "keywords": [
                        "药明康德",
                        "2020年业绩",
                        "符合预期",
                        "强劲增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}